A Prospective, Single-Center, Randomized, Triple-Blinded, Placebo-Controlled Study of IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions

Trial Profile

A Prospective, Single-Center, Randomized, Triple-Blinded, Placebo-Controlled Study of IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Apr 2018

At a glance

  • Drugs Anakinra (Primary)
  • Indications Ligament injuries; Osteoarthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Apr 2018 Last checked against ClinicalTrials.gov record.
    • 02 Apr 2018 Planned initiation date changed from 1 Mar 2018 to 1 Jun 2018.
    • 08 Feb 2018 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top